Unspecified gene therapy candidate

· Spur Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Unspecified gene therapy candidate, covering 2025-11-04 to 2025-11-04. Get the full timeline:

Most recent: Clinical Trial Update: A Gene Therapy Study in Patients With Gaucher Disease Type 1 [Phase 1]